Medical Stethoscope and Heart on Blue Background Health Care Insurance Concept

Featured image by Nora Carol Photography/Getty Images

Buyouts

Are healthcare PE funds losing their advantage?

Healthcare specialist funds of recent vintages performed on par with PE funds investing in other strategies.

For years, healthcare investing has been one of the top-performing strategies in the buyout landscape. Now, data shows these specialist funds may be losing their edge.

Investors drawn to healthcare PE funds by their historical performance may be disappointed as the latest vehicles struggle to replicate the success of earlier vintages.

Healthcare specialist funds in 2015 to 2017 and 2018 to 2020 vintage buckets performed almost on par with other PE funds of the same vintage years, based on a PitchBook analysis of the internal rate of return of 890 PE funds, detailed in the H1 2024 Healthcare Funds Report.

Even so, they have yet to achieve the stellar returns seen in their counterparts from 2012 to 2014, which significantly outperformed the broader PE market.

“The trend does look like the performance advantage that used to exist for healthcare has gradually eroded over time,” said Rebecca Springer, PitchBook’s lead healthcare analyst and the author of the Healthcare Funds Report.

When comparing the total value to paid-in capital, or TVPI, another key metric used to gauge fund performance, healthcare funds from recent vintage years slightly outperformed other PE strategies.

A slower pace of exits

The report also examined another proxy for healthcare PE fund performance: exit activity. While not always guaranteed, a more rapid exit from an investment can often lead to a higher return.

For assets acquired between 2012 and 2015, PE firms managed to sell a larger proportion of healthcare assets than their other PE investments.

However, that advantage diminished in the following years, particularly between 2020 and 2022, when healthcare asset sales lagged behind other PE asset sales.

Competition among PE buyers increased, valuations skyrocketed, exit activity stalled, and some other post-pandemic market obstacles lingered. All these factors made it more difficult for GPs to repeat the winning formula for their healthcare investments.

“PE exits, in general, have struggled over the past two years, but healthcare has been uniquely challenged by issues like labor shortages and regulatory scrutiny and, therefore, has struggled even more than the other sectors to realize investments over the last two years,” Springer said.

Popular segments such as healthcare services and healthcare IT were impacted by these adverse market conditions, Springer said.

If these trends persist, healthcare funds of the most recent vintages — from 2019 to 2022 — may underperform the rest of the PE industry.

To combat these challenges, specialist fund managers have been pursuing different strategies to gain an edge in healthcare investing, including providing more hands-on support for their portfolio companies and strengthening research capacity to find niche areas where they can establish footholds.

Many of these developments happened in the last five years, so it will take time for the efforts to show up in performance data, Springer said.

Featured image by Nora Carol Photography/Getty Images

Learn about our editorial standards.